Question 1

How many shares of CRNX does JACOBS LEVY EQUITY MANAGEMENT, INC own?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC previously held 0 shares of CRNX (CRINETICS PHARMACEUTICALS IN) before exiting the position in 2021-Q3.

Question 2

What is JACOBS LEVY EQUITY MANAGEMENT, INC's CRNX position worth?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC's CRNX position was last reported at $0 in 2021-Q3 before the exit.

Question 3

Is JACOBS LEVY EQUITY MANAGEMENT, INC buying or selling CRNX?

Accepted Answer

In 2021-Q3, JACOBS LEVY EQUITY MANAGEMENT, INC exited their CRNX position entirely (-100.0% change in shares).

Question 4

When did JACOBS LEVY EQUITY MANAGEMENT, INC first buy CRNX?

Accepted Answer

Based on available 13F filings, JACOBS LEVY EQUITY MANAGEMENT, INC first reported a position in CRNX in 2020-Q4. They have held the position across 4 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2021-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$20.80	0
2021-Q2	Decreased	27,839	-62.0%	$525,000	0.0%	$19.15	0
2021-Q1	Decreased	73,156	-17.5%	$1.1M	0.0%	$15.44	0
2020-Q4	New	88,644	-	$1.3M	0.0%	$13.69	35

CRNX4 quarters

CRNX
4 quarters